Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study
CANCER CHEMOTHERAPY AND PHARMACOLOGY, cilt.74, sa.4, ss.751-756, 2014 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 74 Sayı: 4
- Basım Tarihi: 2014
- Doi Numarası: 10.1007/s00280-014-2558-x
- Dergi Adı: CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.751-756
- Anahtar Kelimeler: Chronomodulated chemotherapy, Capecitabine, Neoadjuvant chemoradiotherapy, Rectal cancer, METASTATIC COLORECTAL-CANCER, DIHYDROPYRIMIDINE DEHYDROGENASE, PREOPERATIVE RADIOTHERAPY, RADIATION-THERAPY, FOLINIC ACID, CHEMOTHERAPY, FLUOROURACIL, OXALIPLATIN, PHARMACOKINETICS, COMBINATION
- İstanbul Üniversitesi Adresli: Evet
Özet
The aim of this study was to evaluate efficacy and safety of chronomodulated capecitabine administered according to a specific time schedule (Brunch Regimen: Breakfast and Lunch) as a part of neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.